Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.

The Journal of molecular diagnostics : JMD - 1 Jul 2024

Artymiuk Cody J, Basu Shubham, Koganti Tejaswi, Tandale Pratyush, Balan Jagadheshwar, Dina Michelle A, Barr Fritcher Emily G, Wu Xianglin, Ashworth Taylor, He Rong, Viswanatha David S

Abstract excerpt

Lymphoid malignancies are a heterogeneous group of hematological disorders characterized by a diverse range of morphologic, immunophenotypic, and clinical features. Next-generation sequencing (NGS) is increasingly being applied to delineate the complex nature of these malignancies and identify high-value biomarkers with diagnostic, prognostic, or therapeutic benefit. However, there are various challenges in using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to INDEL Mutation

Share to Lymphoma

Share to Lymphoproliferative Disorders

Share to Mutation

Share to Polymorphism, Single Nucleotide

Share to Reproducibility of Results

Source

Identifiers

PMID: 38582399
DOI: 10.1016/j.jmoldx.2024.03.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.PMID 38582399Read ↗

LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.Semantic proximity Read ↗

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.Semantic proximity Read ↗

Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.Semantic proximity Read ↗

Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.Semantic proximity Read ↗

Next-generation sequencing for lymphoid neoplasms: Real-world utility from a clinical assay.Semantic proximity Read ↗

Genomic profiling for clinical decision making in lymphoid neoplasmsSemantic proximity Read ↗

Applications of next-generation sequencing in hematologic malignancies.Semantic proximity Read ↗

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Semantic proximity Read ↗

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read ↗

Genome sequencing of lymphoid malignancies.Semantic proximity Read ↗

A genetic profiling guideline to support diagnosis and clinical management of lymphomas.Semantic proximity Read ↗

The Need for a Consensus Next‐generation Sequencing Panel for Mature Lymphoid MalignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.